Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27576098 | 0.92 | TRPA1 (0.34) | TRPA1LMNACA2ALDH1A1CYP3A4 | |
| SCHEMBL2469115 | 0.87 | ALDH1A1 (0.48) | LMNACA2ALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL27558876 | 0.80 | ALDH1A1 (0.50) | LMNACA2ALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL2344657 | 0.78 | NPSR1 (0.35) | ALDH1A1L3MBTL1 | |
| SCHEMBL2347611 | 0.75 | MEN1 (0.41) | LMNAALDH1A1 | |
| SCHEMBL4272440 | 0.72 | ALDH1A1 (0.42) | LMNAALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL2325371 | 0.72 | LTA4H (0.44) | ALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL2325321 | 0.70 | LTA4H (0.44) | LMNAALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL2348524 | 0.69 | LTA4H (0.43) | LMNAALDH1A1CYP3A4L3MBTL1 | |
| SCHEMBL2347755 | 0.69 | LTA4H (0.43) | LMNAALDH1A1CYP3A4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1460056-B1 | METHOD FOR PRODUCING A CARBONIC ESTER | ASAHI KASEI CHEMICALS CORP (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-7435842-B2 | Process for producing carbonic ester | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2008-10-14 | — | — | US | disclosed |
| US-20050080274-A1 | Process for producing carbonic ester | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1460056-A1 | PROCESS FOR PRODUCING CARBONIC ESTER | Asahi Kasei Chemicals Corporation (JP) | 2004-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080274-A1 | Process for producing carbonic ester | CYP2E1, ADH1A, ALKBH3 | TRPA1 4540/4885LMNA 4400/4885CA2 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.